Systech International, a provider of serialization, traceability, and brand protection technologies, has established an office in Mumbai, India in response to a growing need for its solutions and an expanding client base in the region.

To further support its entry, Systech will convene its next Uniquity Global Conference in Mumbai on October 6, 2016. The focus of Uniquity India will be on global serialization regulations affecting the pharmaceutical industry and how effective technologies will be necessary to meet a wide range of compliance requirements. Attendance at this exclusive event is by invitation only, with confirmation to selected qualified representatives.

“With the incredible opportunity to service the pharmaceutical industry comes the demand for globally-compliant solutions that meet the vast array of complex regulations that continue to evolve,” said Robert DeJean, chief executive officer, Systech International. “As a result, there’s a need for solutions that are comprehensive, versatile, and cost-effective. Systech’s industry-leading serialization and track-and-trace offerings have been proven for more than 30 years as the best solutions to meet this need.”

Pharmaceutical manufacturers in India supply a high volume of medicines to every market in the world, and the nation’s pharmaceutical export segment has more than doubled from $7.8 billion in 2008 to $16.5 billion in 2014, according to the Indian Ministry of Commerce and Industry. In 2016, sales are expected to increase by nearly 84% to $26.1 billion with generic drugs dominating, accounting for nearly 70% of the market. Furthermore, over 55% of exports from India are to highly regulated markets whose governments have enacted stringent serialization and tracing regulations. 

“The problem is that no two of these regulations are the same, and therefore Indian exporters must not only comply with all the individual mandates, but also keep abreast of a rapidly-changing regulatory landscape,” said Dr. Avi Chaudhuri, who is spearheading Systech’s India expansion. “Our core commitments to the industry are that we provide a comprehensive set of solutions and ensure full compliance against any and all new regulations that come into force.”

Systech offers a full suite of software applications to manage these complex requirements, allowing serialization mandates to be met anywhere in the world—including the export serialization requirements of the Indian Directorate General of Foreign Trade (DGFT). Systech is already seeing significant demand for its solutions as Indian pharmaceutical companies rush toward complying with the looming deadlines for key regulations such as the US DSCSA, EU FMD, and others.